VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

EAU 2020 | EUPROMS: prostate cancer patient-driven QoL

André Deschamps • 18 Jul 2020
EAU 2020
Genitourinary Cancer Prostate Cancer

André Deschamps, of Europa Uomo, Antwerpen, Belgium, discusses the effect of prostate cancer treatment as evaluated in the EUPROMS study, the first ever patient driven quality of life (QoL) study. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

More from André Deschamps

0:58
The Europa Uomo advocacy movement
André Deschamps • 18 Jul 2020

Related Videos

3:37
Challenges of MRI in prostate cancer
Anwar Padhani • 14 Oct 2020
4:34
Optimising treatment for advanced urothelial cancer: combination, maintenance or sequencing?
Arlene Siefker-Radtke • 14 Oct 2020
1:41
Challenges and treatment advances in mHSPC
Ursula Vogl • 14 Oct 2020
1:25
Improving precision of high-quality prostate cancer MRI
Anwar Padhani • 14 Oct 2020
VJOncology VJOncology is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJOncology is intended for healthcare professionals